Cardiovascular-Specific Labs Flashcards
Troponin I (cTnI) and T (cTnT)
two biomarkers that are sensitive, specific indicators to the myocardium of the heart
released when cardiac injury occurs (6 hours after insult to 3 days)
greatest use for diagnosing a myocardial infarction (> 0.10 ng/mL)
Newer highly-sensitive assays can detecting circulating troponin in healthy “normal” individuals at levels as low as (N < 0.03 ng/mL) in their blood
troponin may also be elevated in other situations in which there is stress to the heart but not in the setting of myocardial infarction:
rhabdomyolysis with cardiac damage
renal failure
inflammatory disease (myocarditis or endocarditis)
hypertrophic cardiomyopathy
drug toxicity
critical illness
congestive heart failure
cardiac surgery (ablation, defibrillation, and cardioversion)
large body-surface-area burns aortic valve disease
aortic dissection
pulmonary embolism
pulmonary hypertension
COPD
blunt thoracic damage
acute neurologic disease (stroke or subarachnoid hemorrhage)
B-Type Natriuretic Peptide (BNP)
strongest independent predictor of congestive heart failure (CHF), with an odds ratio of 29.60
BNP <100 pg/mL
Indicates no heart failure
BNP 100–300 pg/mL
Class I – Cardiac disease, but no symptoms and no limitation in ordinary physical activity (i.e. no shortness of breath when walking, climbing stairs, etc.).
Symptoms-based approach when determining appropriateness for activity.
BNP > 300 pg/mL
Class II – Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.
Symptoms-based approach when determining appropriateness for activity
BNP > 600 pg/mL
Class III – Marked limitation in activity due to symptoms, even during less-than-ordinary activity (i.e. walking short distances [20–100 m]). Comfortable only at rest.
Symptoms-based approach when determining appropriateness for activity
BNP > 900 pg/m
Class IV – Severe limitations. Experiences symptoms even while at rest.
Symptoms-based approach when determining appropriateness for activity
The following confounding factors can contribute to an elevated BNP:
gender (females have higher levels)
race (African-American and Hispanic subjects have higher levels than Caucasians)
anemia
atrial fibrillation
Obesity is associated with lower BNP levels
Creatinine Kinase (CK) =
is an isoenzyme that is released into the blood when skeletal, brain, or cardiac muscle is injured
Creatinine Kinase (CK) norms =
Normal = 30-170 U/L Adult
Males: 52-336 U/L Adult
Females: 38-176 U/L
CK1-BB brain tissue
Rarely present, but described as a marker for adenocarcinoma of the prostate, breast, ovary, colon, gastrointestinal tract, and for small-cell anaplastic carcinoma of lung
BB has been reported with severe shock and/or hypothermia, infarction of bowel, brain injury, and stroke
CK2-MB cardiac muscle
Commonly elevated in myocardial infarction within 3-6 hours of cardiac injury and then returns to normal within 2-3 days (peaks 18-24 hours).
Useful for diagnosing re-infarction.
Might be elevated in cases of carbon monoxide poisoning, pulmonary embolism, hypothyroidism, crush injuries, and muscular dystrophy.
Sensitivity and specificity are not as high as troponin levels.
CK3-MM skeletal muscle
Can have an increase following strenuous exercise, but not considered rhabdomyolysis.
Intramuscular injection can increase